Your Solutions
BIOMEDTRACKER
Real-time Event Tracking & Drug Development Analysis
管線研發追蹤、獲批前景分析、商業資訊、調研報告
DATAMONITOR HEALTHCARE
Disease Competitive Analysis, 10-20 Years Market Forecast, KOL Insights
疾病競爭分析、10-20年市場預測、KOL專訪
Meet the team
Julie Guan (China)
Head of Strategic Accounts
Citeline
Youmin Zhu (China)
Client Success Manager
Citeline
Training & Help
We provide product training support via online sessions/pre-recorded materials, please click below to access relevant contents, or reach out to this email for any customized training request: [email protected]
我們提供各產品的使用培訓支持，請點擊下列查閲相關培訓資源，若有特定培訓需求或安排則可聯絡：[email protected]
For access or technical issues, please contact your dedicated support team via 'Meet the Team', or contact Client Service team via below email:
若有任何登錄問題，請切換至Meet the Team版面並聯絡對接服務團隊，或可聯絡全球/亞太客服團隊：
Global - [email protected] (English only)
APAC - [email protected] (via English/Chinese)
Require Research Support?
Ask-the-Analyst™
Ask-the-Analyst™
Your status as a loyalty partner includes unlimited access to our highly acclaimed Ask-the-Analyst™ service. With a 24-hour response time, Ask-the-Analyst offers you authoritative information to help you make faster, smarter business decisions.
作爲重點合作夥伴，貴司用戶均可無限量使用「Ask-the-Analyst™」分析師咨詢服務。分析師團隊將會在24小時内回復（工作日），并爲您提供信息收集或專業見解，最終助您做出更快、更明智的業務決策。
Our Ask-the-Analyst team of industry experts leverages the complete suite of pharma intelligence products and publicly available sources to bring you the answers you’re looking for, while your information and all questions received are strictly confidential.
由業界專家組成的Ask the Analyst團隊將結合内部數據與公開領域資源爲您提供相關信息支持，您的個人資訊與提問内容均會被嚴格保密。
Latest Pharma Monthly Newsletter
Edition: February 2026
EDITORIAL CONTENTS (incl. Podcasts, Webinars)
- Notable Podcast: Drug Fix: US FDA Versus Moderna And The Changing Role Of Refuse To File Actions
- Notable Webinar: Design to Recruit: Connecting Feasibility and Patient Recruitment (4pm GMT, March 18 | Register)
- Notable Webinar: Orphan Drugs: A safe(r) passage amid stormy waters? (3pm GMT, March 17 | Register)
DEALS & FINANCING (incl. M&As, Licensing, Financing)
- Notable M&A: Gilead Sciences to Acquire Partner Arcellx for $7.8B
- Notable M&A: Masimo to be Acquired by Danaher for $180.00 Per Share ($9.9B)
- Notable Licensing: Astellas, Vir Biotechnology Enter Global Collaboration For VIR-5500 totalling $1.7B ($315M upfront)
- Notable Licensing: Innovent Enters Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology totalling $8.8B ($350M upfront)
- Notable Financing: Generate Biomedicines Nets $374M in IPO
- Notable Financing: Slate Medicines Raises $130M in Series A Round
KEY R&D EVENTS (incl. Top-line Readouts, Analyst Commentary, Approval/CRL)
- Notable Analysis: AstraZeneca | Breztri Aerosphere delivering promising Phase III results in asthma trial may face an uphill commercial battle
- Notable Analysis: Spruce Biosciences | Spruce reports positive FDA Type B meetings for TA ERT and moves anticipated BLA submission to Q4 2026
- Notable Analysis: Incyte Corp. | FIGHT-209 termination highlights limited efficacy of single-agent FGFR inhibition in recurrent glioblastoma
- Notable Analysis: Protara Therapeutics | TARA-002 falls short of expectations in BCG-unresponsive patients in the ADVANCED-2 trial
- Notable Analysis: BioMarin Pharma | Hemophilia A gene therapy Roctavian withdrawn from the market
- Notable Analysis: Pharming Group | FDA issues complete response letter for Pharming’s Joenja pediatric sNDA, citing dosing and manufacturing concerns
RESEARCH REPORTS (incl. Forecast, Thought Leadership, KOL Interview)
- Notable Report: Dealmaking & Financing Quarterly Statistics, Q4 2025
- Notable Report: 2026 Biopharma Financing Focus: The Data, Deals and Discipline Reshaping Growth
- Notable Report: Clinical Disclosure in 2026: How Misalignment Impacts Company Valuation and Litigation Risk
- Notable Report: The State of Clinical Trial Transparency: 2025 Developments and 2026 Predictions
- Notable Report: Earning Their Trust: Challenges and Best Practices in Rare Disease Patient Recruitment
- Notable Report: The AI Reform of Clinical Trials: How Biopharma Benefits
- Notable Report: Epidemiology & Market Forecast - Atopic Dermatitis | Cystic Fibrosis | Duchenne Muscular Dystrophy
- Notable Report: KOL Interview - Atopic Dermatitis | Autism Spectrum | Duchenne Muscular Dystrophy | Dry AWD | Neuroendocrine Tumors | Sjögren’s Disease
Latest Editorial Podcasts
